Trial record 1 of 1 for:
03637491
A Study of Avelumab, Binimetinib and Talazoparib in Patients With Locally Advanced or Metastatic RAS-mutant Solid Tumors
![]() |
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
ClinicalTrials.gov Identifier: NCT03637491 |
Recruitment Status :
Terminated
(Available clinical data has shown limited anti-tumor activity and reaching target study drug dose levels may not be feasible.)
First Posted : August 20, 2018
Last Update Posted : March 15, 2021
|
Sponsor:
Pfizer
Information provided by (Responsible Party):
Pfizer
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
Recruitment Status : | Terminated |
---|---|
Actual Primary Completion Date : | December 3, 2020 |
Actual Study Completion Date : | February 2, 2021 |
Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):